179 related articles for article (PubMed ID: 27265455)
1. Sulfate-binding protein, CysP, is a candidate vaccine antigen of Moraxella catarrhalis.
Murphy TF; Kirkham C; Johnson A; Brauer AL; Koszelak-Rosenblum M; Malkowski MG
Vaccine; 2016 Jul; 34(33):3855-61. PubMed ID: 27265455
[TBL] [Abstract][Full Text] [Related]
2. ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence.
Murphy TF; Brauer AL; Johnson A; Kirkham C
PLoS One; 2016; 11(7):e0158689. PubMed ID: 27391026
[TBL] [Abstract][Full Text] [Related]
3. Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis.
Otsuka T; Kirkham C; Johnson A; Jones MM; Murphy TF
Infect Immun; 2014 Aug; 82(8):3503-12. PubMed ID: 24914218
[TBL] [Abstract][Full Text] [Related]
4. Vaccine targets against Moraxella catarrhalis.
Ren D; Pichichero ME
Expert Opin Ther Targets; 2016; 20(1):19-33. PubMed ID: 26565427
[TBL] [Abstract][Full Text] [Related]
5. A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.
Murphy TF; Brauer AL; Johnson A; Wilding GE; Koszelak-Rosenblum M; Malkowski MG
Clin Vaccine Immunol; 2017 Sep; 24(9):. PubMed ID: 28659326
[No Abstract] [Full Text] [Related]
6. Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.
Ruckdeschel EA; Brauer AL; Johnson A; Murphy TF
Vaccine; 2009 Nov; 27(50):7065-72. PubMed ID: 19786139
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatics Identifies a Lactoferrin Binding Protein A Peptide as a Promising Vaccine With a Global Protective Prospective Against Moraxella catarrhalis.
Yassin GM; Amin MA; Attia AS
J Infect Dis; 2016 Jun; 213(12):1938-45. PubMed ID: 26908723
[TBL] [Abstract][Full Text] [Related]
8. Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.
Yang M; Johnson A; Murphy TF
Infect Immun; 2011 Feb; 79(2):846-57. PubMed ID: 21134967
[TBL] [Abstract][Full Text] [Related]
9. A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.
Perez AC; Murphy TF
Hum Vaccin Immunother; 2017 Oct; 13(10):2322-2331. PubMed ID: 28853985
[TBL] [Abstract][Full Text] [Related]
10. The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis.
Otsuka T; Kirkham C; Brauer A; Koszelak-Rosenblum M; Malkowski MG; Murphy TF
Infect Immun; 2016 Feb; 84(2):432-8. PubMed ID: 26597985
[TBL] [Abstract][Full Text] [Related]
11. Current progress with Moraxella catarrhalis antigens as vaccine candidates.
Mawas F; Ho MM; Corbel MJ
Expert Rev Vaccines; 2009 Jan; 8(1):77-90. PubMed ID: 19093775
[TBL] [Abstract][Full Text] [Related]
12. Potential impact of a Moraxella catarrhalis vaccine in COPD.
Perez AC; Murphy TF
Vaccine; 2019 Sep; 37(37):5551-5558. PubMed ID: 28185742
[TBL] [Abstract][Full Text] [Related]
13. Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development.
Blakeway LV; Tan A; Peak IRA; Seib KL
Microbiology (Reading); 2017 Oct; 163(10):1371-1384. PubMed ID: 28893369
[TBL] [Abstract][Full Text] [Related]
14. Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A.
Perez AC; Johnson A; Chen Z; Wilding GE; Malkowski MG; Murphy TF
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203544
[TBL] [Abstract][Full Text] [Related]
15. Role of the zinc uptake ABC transporter of Moraxella catarrhalis in persistence in the respiratory tract.
Murphy TF; Brauer AL; Kirkham C; Johnson A; Koszelak-Rosenblum M; Malkowski MG
Infect Immun; 2013 Sep; 81(9):3406-13. PubMed ID: 23817618
[TBL] [Abstract][Full Text] [Related]
16. Moraxella catarrhalis, a human respiratory tract pathogen.
Murphy TF; Parameswaran GI
Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579
[TBL] [Abstract][Full Text] [Related]
17. Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection.
Ruckdeschel EA; Kirkham C; Lesse AJ; Hu Z; Murphy TF
Infect Immun; 2008 Apr; 76(4):1599-607. PubMed ID: 18227159
[TBL] [Abstract][Full Text] [Related]
18. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.
Murphy TF
Expert Rev Vaccines; 2005 Dec; 4(6):843-53. PubMed ID: 16372880
[TBL] [Abstract][Full Text] [Related]
19. Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease.
Adlowitz DG; Kirkham C; Sethi S; Murphy TF
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):139-46. PubMed ID: 16420607
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for Moraxella catarrhalis.
McMichael JC
Vaccine; 2000 Dec; 19 Suppl 1():S101-7. PubMed ID: 11163472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
